J Frontier Co.,Ltd.

TSE:2934 Stock Report

Market Cap: JP¥9.6b

J FrontierLtd Past Earnings Performance

Past criteria checks 2/6

J FrontierLtd's earnings have been declining at an average annual rate of -10.3%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 11.6% per year. J FrontierLtd's return on equity is 5.4%, and it has net margins of 0.3%.

Key information

-10.26%

Earnings growth rate

-9.10%

EPS growth rate

Healthcare Industry Growth7.93%
Revenue growth rate11.64%
Return on equity5.38%
Net Margin0.33%
Next Earnings Update14 Jan 2026

Recent past performance updates

Recent updates

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Aug 25
Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Jul 29
Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Mar 19
Does J FrontierLtd (TSE:2934) Have A Healthy Balance Sheet?

Revenue & Expenses Breakdown

How J FrontierLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:2934 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 2521,076708,2980
31 May 2521,504878,6750
28 Feb 2521,686-1,3289,2450
30 Nov 2420,544-1,7939,0950
31 Aug 2418,919-2,0748,8450
31 May 2417,714-2,0868,5050
29 Feb 2416,501-1,9339,2820
30 Nov 2315,754-1,8369,1640
31 Aug 2315,525-1,8009,0020
31 May 2316,844-1,8998,6310
28 Feb 2317,148-5556,7600
30 Nov 2217,067-1045,7350
31 May 2211,8764004,6080

Quality Earnings: 2934 has a large one-off gain of ¥47.0M impacting its last 12 months of financial results to 31st August, 2025.

Growing Profit Margin: 2934 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2934 has become profitable over the past 5 years, growing earnings by -10.3% per year.

Accelerating Growth: 2934 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 2934 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (8.4%).


Return on Equity

High ROE: 2934's Return on Equity (5.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/01 10:01
End of Day Share Price 2025/10/31 00:00
Earnings2025/08/31
Annual Earnings2025/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

J Frontier Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keita FujinoThe Stock Research Center